agm, page-4

BIg Pharma will not be interested until well into/after phase 2 trails with some positive efficacy results . Until then, the SP is down as cap raising/dilution and a small education in Aussie Biotech reality hits the newby investors in this stock. Don't get me wrong, the technology appears to have great potential but if you're expected a buy out or licensing agreement in the next year or some miraculous spike in SP you will unfortunately be sorely dissapointed. The only good news that has the potential to inject some life into VLA will be a cash injection from CBIO or some more spin from the Bulletin Mag. Remember, any short or medium term upside here is Blue Sky and therefore impossible to predict. One thing you can be sure of is what i've said above. Cash strapped, no efficacy in humans and no chance of a deal without it. This is a way off yet !